LPL Financial »

Verve Therapeutics shares owned by LPL Financial

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by LPL Financial from 13F filings

Historical chart of LPL Financial investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by LPL Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by LPL Financial

Quarter filed Position value Share count Share price at filing
2024-06-30 $64k 13k 4.88
2024-03-31 $589k 44k 13.28

More positions owned by LPL Financial

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Vanguard Index Fds Total Stk Mkt (VTI)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Ishares Tr Core Msci Eafe (IEFA)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Ishares Tr Us Treas Bd Etf (GOVT)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Amazon (AMZN)

View all positions for LPL Financial

Top funds holding Verve Therapeutics

Alphabet
BlackRock
Vanguard Group
T. Rowe Price Investment Management
Millennium Management
State Street Corporation
Casdin Capital
ARK Investment Management
Novo A/S
Arch Venture Corp
Baker Bros. Advisors
Jpmorgan Chase & Co
Geode Capital Management
Redmile Group
Goldman Sachs Group

View all funds holding Verve Therapeutics